Clinical Trials List
Protocol NumberNKCND420/201112
2012-09-03 - 2014-09-03
Phase II
Study ended1
-
Trial Applicant
NANG KUANG PHARMACEUTICAL CO., LTD.
-
Sponsor
-
Trial scale
Taiwan Single Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- 黃品逸 Division of Radiation Therapy
- Jiing-Chyuan Luo Digestive System Department
- Wen-Hu Hsu Division of Thoracic Surgery
- 林可瀚 Division of Nuclear Medicine
- 陳盛裕 Division of Radiation Therapy
- Yu-Chung Wu Division of Thoracic Surgery
- 吳美翰 Division of Radiology
- Sheng-Yu Chen Division of Radiation Therapy
- Yu-Ming Liu Division of Radiation Therapy
- 周德盈 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Study ended
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
53 participants
-
Global
0 participants
